Selective is a pharmacological term of art describing receptor pathway specificity it is not a safety claim
These pathways influence appetite, fullness, insulin response, and energy metabolism in different ways
Naweed Imam Syed, Professor, Department of Cell Biology at the University of Calgary, for their useful input and guidance for the duration of the research project
He also led the company through its IPO
Semaglutide is already FDA-approved for weight loss, but tirzepatide is still waiting for approval
There were reports that some people experienced a slight increase in their heart rate, which has also been seen with GLP-1 agonists